| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/2010 | US20100166748 C5 Antigens and Uses Thereof |
| 07/01/2010 | US20100166741 Altered br-3 binding polypeptides |
| 07/01/2010 | US20100166736 Immunostimulatory oligonucleotide multimers |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166732 Small streptococcus pyogenes antigens and their use |
| 07/01/2010 | US20100166729 Modified factor VII polypeptides and uses thereof |
| 07/01/2010 | US20100166728 Novel Highly Functional Enzyme Having Modified Substrate-Specificity |
| 07/01/2010 | US20100166723 Genes encoding nematode toxins |
| 07/01/2010 | US20100166707 Extracellular matrix/metastasis modifier genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 07/01/2010 | US20100166704 Methods and compositions for inhibition of viral replication |
| 07/01/2010 | US20100166703 Use of il-6/il-6 chimera in huntington's disease |
| 07/01/2010 | US20100166676 RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS |
| 07/01/2010 | US20100166658 Monkey homolog of human oncostatin m |
| 07/01/2010 | DE112008001326T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
| 07/01/2010 | DE102008055120A1 Präparation und Amplifikation von Nukleinsäuren mittels magnetischer Partikel Preparation and amplification of nucleic acids using magnetic particles |
| 07/01/2010 | CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | CA2748357A1 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 07/01/2010 | CA2748354A1 Method for producing lactic acid and method for producing polylactic acid |
| 07/01/2010 | CA2748308A1 Hnrnp a3 related peptides and use thereof for diagnosis of rheumatoid arthritis |
| 07/01/2010 | CA2748180A1 Oncolytic adenoviral vectors and methods and uses related thereto |
| 07/01/2010 | CA2748149A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |
| 07/01/2010 | CA2748135A1 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum |
| 07/01/2010 | CA2748125A1 Egfr-homing double-stranded rna vector for systemic cancer treatment |
| 07/01/2010 | CA2748015A1 Protein substance having triple helix structure and manufacturing method therefor |
| 07/01/2010 | CA2748011A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |
| 07/01/2010 | CA2747826A1 Axmi-150 delta-endotoxin gene and methods for its use |
| 07/01/2010 | CA2747812A1 Pesticidal genes from brevibacillus and methods for their use |
| 07/01/2010 | CA2747686A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | CA2747492A1 Production of ethanol from lignocellulosic biomass |
| 07/01/2010 | CA2746892A1 Tor-interacting proteins (tips) and genes therefor |
| 07/01/2010 | CA2746118A1 Hybrid alpha-amylases |
| 07/01/2010 | CA2746009A1 Single recombination system and methods of use |
| 07/01/2010 | CA2745371A1 Methods, reagents and kits for the identification of modulators of voltage-gated sodium channels |
| 07/01/2010 | CA2745311A1 Mammalian expression vector comprising human beta globin intron ii |
| 07/01/2010 | CA2745189A1 Methods for detection of sepsis |
| 06/30/2010 | EP2202319A1 Nucleic acid probe, and method for production of probe polymer |
| 06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
| 06/30/2010 | EP2202314A1 Use of subtilisin (RNR9) polynucleotides for achieving a pathogen resistance in plants |
| 06/30/2010 | EP2202313A1 Method for preparation of recombinant dna |
| 06/30/2010 | EP2202312A2 DNA polymerases having improved labelled nucleotide incorporation properties |
| 06/30/2010 | EP2202311A2 Use of AHAS mutant genes as selection marker in potato transformation |
| 06/30/2010 | EP2202310A2 Caustic stable chromatography ligands |
| 06/30/2010 | EP2202309A1 Efficient method for nuclear reprogramming |
| 06/30/2010 | EP2202308A2 Methods and compositions for polypeptide engineering |
| 06/30/2010 | EP2202307A1 Method for production of antibody |
| 06/30/2010 | EP2202305A1 Primer for amplification of rrna of bacterium belonging to the genus legionella, detection method, and detection kit |
| 06/30/2010 | EP2202304A1 Modified creatinine amidohydrolase |
| 06/30/2010 | EP2202303A1 Novel glucose dehydrogenase |
| 06/30/2010 | EP2202302A1 Dry composition of reaction compounds with stabilized polymerase |
| 06/30/2010 | EP2202301A1 Herbicide resistant rice |
| 06/30/2010 | EP2202300A1 Glucose-induced inactivation/degradation resistant transporter gene and use thereof |
| 06/30/2010 | EP2202297A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 06/30/2010 | EP2202294A1 Bacterial cells having a glyoxylate shunt for the manufacture of succinic acid |
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202243A2 Antigen binding domains from fish |
| 06/30/2010 | EP2202242A1 Inactivation resistant factor VIII related applications |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2202238A1 Nucleotide Compounds including a rigid linker |
| 06/30/2010 | EP2201130A1 Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease |
| 06/30/2010 | EP2201121A1 Methods of controlling plant seed and organ size |
| 06/30/2010 | EP2201120A2 Gcsf fusion protein systems suitable for high expression of peptides |
| 06/30/2010 | EP2201119A2 Advanced cervical cell screening methods |
| 06/30/2010 | EP2201117A2 Extracellular targets for alzheimer's disease |
| 06/30/2010 | EP2201116A1 Means and methods for shrna mediated conditional knockdown of genes |
| 06/30/2010 | EP2201115A2 Mutants having capability to produce 1,4-butanediol and method for preparing 1,4-butanediol using the same |
| 06/30/2010 | EP2201114A1 Permanent inactivation of nucleases |
| 06/30/2010 | EP2201113A2 Method of identifying agents which modulate the activity of calcium-activated chloride channel |
| 06/30/2010 | EP2201112A2 Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| 06/30/2010 | EP2201109A1 Truncated secretory aspartyl proteinase 2 |
| 06/30/2010 | EP2201033A2 Methods of treating cancer using notch pathway inhibitors |
| 06/30/2010 | EP2201031A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 06/30/2010 | EP2201030A2 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 06/30/2010 | EP2201029A1 Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| 06/30/2010 | EP2201023A2 Affinity tag |
| 06/30/2010 | EP2201022A1 Composition of asymmetric rna duplex as microrna mimetic or inhibitor |
| 06/30/2010 | EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 06/30/2010 | EP2200636A1 Protein |
| 06/30/2010 | EP2200634A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 06/30/2010 | EP1904636B1 Improvements in or relating to protein production |
| 06/30/2010 | EP1904632B1 A microorganism of enterobacteriacae genus haboring genes associated with l-carintine biosynthesis and methos of producing l-carnitine using the microorganism |
| 06/30/2010 | EP1819833B1 Genetic variant of the annexin a5 gene |
| 06/30/2010 | EP1721985B1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 06/30/2010 | EP1531180B1 Method of diagnosing risk of myocardial infarction |
| 06/30/2010 | EP1496359B1 Substrates for hybridization and method of using the same |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | EP1390535B1 Combinatorial libraries of monomer domains |
| 06/30/2010 | EP1036164B1 Chemokine alpha-5 |
| 06/30/2010 | CN1944648B Rice Cyp2 gene for increasing plant salt tolerance |
| 06/30/2010 | CN1884517B Method and uses for expressing polypeptide in endosperm using cereal non-storage protein as fusion vector |
| 06/30/2010 | CN1821407B High efficiency stable expression system of transgene tomato |
| 06/30/2010 | CN1706952B Hepatitis B surface antigen gene and its application |
| 06/30/2010 | CN101765660A Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 06/30/2010 | CN101765659A Method for production of L-lysine |
| 06/30/2010 | CN101765658A Multizymes and their use in making polyunsaturated fatty acids |
| 06/30/2010 | CN101765609A Plants having enhanced yield-related traits and a method for making the same |
| 06/30/2010 | CN101765365A Genetic basis for improved milling performance |
| 06/30/2010 | CN101760566A Detection method on mutant site of ribonucleotide of HBV gene |
| 06/30/2010 | CN101760554A Primer sequence for detecting resistance frequency of botrytis cinerea population to strobilurin fungicide and method thereof |
| 06/30/2010 | CN101760550A Research on location of molecular markers of powdery mildew resistance genes |
| 06/30/2010 | CN101760547A Evaluation and utilization of wheat stripe rust resistance genes |